Nabari, Japan

Takaaki Nishioka


Average Co-Inventor Count = 8.2

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Koka, JP (1990)
  • Nabari, JP (1999 - 2012)

Company Filing History:


Years Active: 1990-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Takaaki Nishioka: Innovator in Quinolone Antibiotics

Introduction

Takaaki Nishioka is a notable inventor based in Nabari, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release preparations of quinolone antibiotics. With a total of five patents to his name, Nishioka's work has had a meaningful impact on antibiotic delivery systems.

Latest Patents

Nishioka's latest patents include innovative formulations for quinolone antibiotics. One of his key inventions is a sustained-release preparation that allows for the delayed release of the active compound. This advancement aims to improve the effectiveness and patient compliance of antibiotic treatments. Another patent focuses on the method of preparing these sustained-release formulations, further enhancing the potential applications of quinolone antibiotics in medical practice.

Career Highlights

Throughout his career, Takaaki Nishioka has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bayer Schering Pharma AG and Bayer Aktiengesellschaft. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Nishioka has collaborated with esteemed professionals in his field, including Roland Rupp and Venkata-Rangarao Kanikanti. These partnerships have likely enriched his research and innovation efforts, leading to the successful development of his patented technologies.

Conclusion

Takaaki Nishioka is a distinguished inventor whose work in quinolone antibiotics has paved the way for advancements in pharmaceutical formulations. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…